LMIM
ABBV icon

Lockheed Martin Investment Management’s AbbVie ABBV Stock Holding History

Lockheed Martin Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.92M Buy
45,610
+470
+1% +$104K 0.36% 53
2025
Q4 		$10.3M Buy
45,140
+4,830
+12% +$1.1M 0.34% 49
2025
Q3 		$9.33M Sell
40,310
-30,390
-43% -$6.19M 0.34% 58
2025
Q2 		$13.1M Buy
70,700
+26,030
+58% +$4.84M 0.48% 41
2025
Q1 		$9.36M Sell
44,670
-1,650
-4% -$321K 0.38% 57
2024
Q4 		$8.23M Sell
46,320
-25,370
-35% -$4.66M 0.33% 60
2024
Q3 		$14.2M Buy
71,690
+19,570
+38% +$3.65M 0.66% 36
2024
Q2 		$8.94M Buy
52,120
+7,350
+16% +$1.22M 0.52% 45
2024
Q1 		$7.42M Sell
44,770
-20,880
-32% -$3.6M 0.54% 41
2023
Q4 		$9.87M Hold
65,650
– – 0.71% 37
2023
Q3 		$9.66M Buy
65,650
+19,240
+41% +$2.82M 0.74% 34
2023
Q2 		$6.25M Sell
46,410
-430
-0.9% -$63.1K 0.36% 52
2023
Q1 		$7.46M Sell
46,840
-8,260
-15% -$1.26M 0.42% 52
2022
Q4 		$8.9M Buy
+55,100
New +$8.45M 0.59% 47
2022
Q1 		– Sell
-81,150
Closed -$11M – 152
2021
Q4 		$11M Hold
81,150
– – 0.59% 47
2021
Q3 		$8.75M Buy
81,150
+11,920
+17% +$1.36M 0.47% 43
2021
Q2 		$7.8M Sell
69,230
-19,910
-22% -$2.24M 0.41% 59
2021
Q1 		$9.65M Sell
89,140
-6,430
-7% -$688K 0.49% 54
2020
Q4 		$10.2M Hold
95,570
– – 0.53% 48
2020
Q3 		$8.37M Sell
95,570
-830
-0.9% -$78.1K 0.52% 41
2020
Q2 		$9.46M Buy
+96,400
New +$8.49M 0.63% 35
2015
Q4 		– Sell
-19,750
Closed -$1.07M – 88
2015
Q3 		$1.07M Sell
19,750
-33,500
-63% -$2.18M 0.12% 63
2015
Q2 		$3.58M Buy
53,250
+45,500
+587% +$2.97M 0.18% 56
2015
Q1 		$454K Buy
+7,750
New +$468K 0.02% 115

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lockheed Martin Investment Management's ABBV Position: Q1 2026 in Review

Lockheed Martin Investment Management increased its AbbVie (ABBV) stake by 1% in Q1 2026, buying an estimated $104K and bringing the position to 45,610 shares worth $9.92M. The position accounts for 0.36% of the portfolio, ranked #53.

Lockheed Martin Investment Management first reported a position in ABBV in Q1 2015 and has held it in 24 quarters since. The position peaked at $14.2M in Q3 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Lockheed Martin Investment Management held 45,610 shares of AbbVie worth $9.92M as of Q1 2026.
  • Lockheed Martin Investment Management bought 470 AbbVie shares in Q1 2026, an estimated $104K.
  • AbbVie made up 0.36% of Lockheed Martin Investment Management's portfolio in Q1 2026, its #53 holding.
  • Lockheed Martin Investment Management first reported a position in AbbVie in Q1 2015 and has held it in 24 quarters since.
  • Lockheed Martin Investment Management's AbbVie position peaked at $14.2M in Q3 2024.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Lockheed Martin Investment Management's 13F filing for Q1 2026, filed 7 May 2026.